Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Metrics Expands Analytical Lab Capabilities | Contract Pharma

What are you searching for?

Sign in
Breaking News

Metrics Expands Analytical Lab Capabilities

Invests in liquid chromatography technologies to provide additional services

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Metrics Contract Services is expanding its analytical lab capabilities with the addition of two new Waters ACQUITY Ultra Performance Liquid Chromatography H-class (UPLC) systems. These additional UPLC systems will help produce better resolution liquid-chromatography separations in shorter analysis times in order to improve characterization of complex samples.
 
“Our clients have been requesting our help with exactly these types of analytical projects, so it’s exciting to expand our capabilities in support of our customers’ programs,” said Jennifer Alligood, associate director of analytical services.
 
The company also recently added a Thermo Scientific iCAP™ Q ICP-MS mass spectrometer and a Milestone UltraWAVE Single Reaction Chamber digestion vessel.
 
“Metrics’ ongoing investment in leading-edge laboratory technologies reflects our commitment to providing clients with scientific excellence — in terms of providing quality data and fast turnaround times, as well as thoughtful interpretation of what those results mean for them,” Alligood added.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics